APELOA CDMO is the contract discovery, development, and manufacturing arm of Apeloa Pharmaceutical Co. Ltd., a subsidiary of the Hengdian Group, one of China’s largest private enterprises. As a CDMO, APELOA is dedicated to delivering high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, and Regulatory Starting Materials (RSMs). With over 30 years of experience, APELOA has established itself as a reliable partner to the global pharmaceutical industry, offering services that span R&D, scale-up, and GMP commercial-scale production.

Services include:
– Small Molecule, Drug Substance Manufacturing (API)
– API Process Development & Manufacturing
– HPAPI (OEB4 & OEB5)
– ADC (Payload + Linker)
– Synthetic Peptides
– LNP (CLs & ILs / PEG-Lipid)
– PROTAC
– Medicinal Chemistry (Med. Chem)
– Full-Time Equivalent (FTE) services
– Analytical Development & Quality Control
– Global Regulatory Affairs CMC Filing
– Formulation Development & Manufacturing

APELOA’s commitment to providing customized solutions, driven by science and exceptional customer service, solidifies its position as a global leader in the development and manufacturing of pharmaceutical products. For more information, please visit apeloa.com.